Wistar researchers successfully tested a simple intervention that could unlock greater anti-tumor power in therapies that use T cells—an approach known as “cell-based therapy,” which uses specially designed T cells to fight cancer.
Wistar researchers successfully tested a simple intervention that could unlock greater anti-tumor power in therapies that use T cells—an approach known as “cell-based therapy,” which uses specially designed T cells to fight cancer.
Leave A Comment